Literature DB >> 9951686

Apoptosis in B-chronic lymphocytic leukaemia.

L M Osorio1, M Aguilar-Santelises.   

Abstract

B-chronic lymphocytic leukaemia (B-CLL) is characterised by the progressive accumulation of monoclonal B cells, which may be the result of several factors leading to extended B-CLL cell lifespan, increased proliferative capacity and diminished cell death. Here we review the implications of several signals mediated by receptors, such as surface IgM, CD6 and CD40, for the B-CLL cell survival, together with data on gene modulation in relation to the apoptosis process in B-CLL cells. We also describe some features of the Fas/FasL system in B-CLL that hypothetically might contribute to the accumulation of leukaemic cells and the progression of the disease, by downregulating the apoptotic response or avoiding the autologous immune response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9951686     DOI: 10.1007/BF02787206

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  81 in total

Review 1.  Apoptosis and programmed cell death in immunity.

Authors:  J J Cohen; R C Duke; V A Fadok; K S Sellins
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 2.  Germinal centres in T-cell-dependent antibody responses.

Authors:  Y J Liu; G D Johnson; J Gordon; I C MacLennan
Journal:  Immunol Today       Date:  1992-01

3.  Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells.

Authors:  D J McConkey; M Aguilar-Santelises; P Hartzell; I Eriksson; H Mellstedt; S Orrenius; M Jondal
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

4.  Mechanism of antigen-driven selection in germinal centres.

Authors:  Y J Liu; D E Joshua; G T Williams; C A Smith; J Gordon; I C MacLennan
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

5.  Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro.

Authors:  R J Collins; L A Verschuer; B V Harmon; R L Prentice; J H Pope; J F Kerr
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

6.  Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40.

Authors:  M A Valentine; K A Licciardi
Journal:  Eur J Immunol       Date:  1992-12       Impact factor: 5.532

7.  Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.

Authors:  A C Fluckiger; J F Rossi; A Bussel; P Bryon; J Banchereau; T Defrance
Journal:  Blood       Date:  1992-12-15       Impact factor: 22.113

8.  Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.

Authors:  M Schena; L G Larsson; D Gottardi; G Gaidano; M Carlsson; K Nilsson; F Caligaris-Cappio
Journal:  Blood       Date:  1992-06-01       Impact factor: 22.113

9.  Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines.

Authors:  K A Knox; M Finney; A E Milner; C D Gregory; M J Wakelam; R H Michell; J Gordon
Journal:  Int J Cancer       Date:  1992-12-02       Impact factor: 7.396

10.  A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

Authors:  S Yonehara; A Ishii; M Yonehara
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.